The UK Vaccine Minister Nadhim Zahawi has said he received a recommendations from the Joint Committee on Vaccination and Immunisation (JCVI) about whether to recommend vaccines for under-18s, BBC News reported on Monday.
Zahawi told BBC Breakfast he will make a statement to Parliament later, but he says the JCVI has recommended that children with medical conditions that make them vulnerable to COVID-19 should be vaccinated, along with those who live with clinically vulnerable people.
He also said the committee recommends that children close to their 18th birthday should have the vaccine.
However, the JCVI will be keeping under review whether or not to vaccinate healthy children aged 12 to 17.
Reportedly, the committee is concerned about some data suggesting there may be rare cases of myocarditis, an inflammation of the heart muscle, linked to the vaccine.
FDA approves Dupixent as first targeted therapy for rare skin disease bullous pemphigoid
Hoth Therapeutics regains Nasdaq compliance
TME Pharma and SERI partner to advance NOX-E36 in ophthalmology through option framework agreement
Merry Life launches TML-6 global Phase II trial for Alzheimer's Disease
Galderma's nemolizumab recommended for NHS funding in England and Wales for atopic dermatitis
UCB announces BIMZELX (bimekizumab-bkzx) three-year data at EULAR 2025
Vivoryon Therapeutics presents positive meta-analysis data for varoglutamstat
Sanofi's rilzabrutinib granted US orphan drug designation for sickle cell disease
Sanofi to acquire Blueprint Medicines in USD9.5bn rare disease deal
Genentech reports sustained two-year benefits from fenebrutinib in relapsing multiple sclerosis
RemeGen secures approval in China for Telitacicept in treating generalised myasthenia gravis
TME Pharma announces extension of financial visibility to May 2026